CN105801553B - A kind of preparation method of Benzochromene derivatives - Google Patents

A kind of preparation method of Benzochromene derivatives Download PDF

Info

Publication number
CN105801553B
CN105801553B CN201610225503.8A CN201610225503A CN105801553B CN 105801553 B CN105801553 B CN 105801553B CN 201610225503 A CN201610225503 A CN 201610225503A CN 105801553 B CN105801553 B CN 105801553B
Authority
CN
China
Prior art keywords
compound
formula
reaction
method described
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610225503.8A
Other languages
Chinese (zh)
Other versions
CN105801553A (en
Inventor
张睿
宁兆伦
李仟
魏庚辉
国光波
郭鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astatech (chengdu) Biological Pharmaceutical Ltd By Share Ltd
Original Assignee
Astatech (chengdu) Biological Pharmaceutical Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astatech (chengdu) Biological Pharmaceutical Ltd By Share Ltd filed Critical Astatech (chengdu) Biological Pharmaceutical Ltd By Share Ltd
Priority to CN201610225503.8A priority Critical patent/CN105801553B/en
Publication of CN105801553A publication Critical patent/CN105801553A/en
Application granted granted Critical
Publication of CN105801553B publication Critical patent/CN105801553B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/32Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
    • C07C29/34Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups by condensation involving hydroxy groups or the mineral ester groups derived therefrom, e.g. Guerbet reaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/46Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans

Abstract

The invention discloses the method for Benzochromene derivatives shown in a kind of formula (I), which can be as the synthetic intermediate of the synthetic intermediate of drug, such as Velpatasvir.The method of the present invention provides a completely new synthetic route for preparing Benzochromene derivatives, entire reaction route total recovery is high, is suitable for large-scale industrial production using cheap and easily-available adjacent fluorine halogeno-benzene as initial feed.

Description

A kind of preparation method of Benzochromene derivatives
Technical field
The present invention relates to a kind of preparation method of Benzochromene derivatives more particularly to the systems of Velpatasvir intermediates Preparation Method.
Background technology
Many Benzochromene derivatives all have extensive pharmacological activity and physiological activity, and there are also Benzochromene derivatives Object can be as the compound of the intermediate for preparing of drug, especially following formula (I a) structure:
It is the important intermediate for preparing hepatitis new drug Velpatasvir.
Patent WO2013075029 discloses a kind of synthetic method of Velpatasvir, is directed to Benzochromene spread out The preparation method of biology, key step are as follows:
But -1 (2 hydrogen) -one of starting material 7- hydroxyl -3,4- dihydronaphthalene of this method first step, which is usually all multistep, closes Into, it is with high costs, also, the catalyst Pd (OPiv) of its second step2With ligand P (4-F-Ph)3Price it is also very expensive.
As it can be seen that being prepared for Benzochromene derivatives, existing method production cost is higher, it is difficult to adapt to large-scale industry The needs of metaplasia production.Therefore, there is an urgent need for explore the industrialized production road of the relatively low Benzochromene derivatives of a production cost at present Line.
Invention content
To solve the above problems, the method that the present invention provides Benzochromene derivatives shown in a kind of formula (I), including it Racemic mixture or chipal compounds:
Wherein, R1、R2、R3、R4、R5And R6Separately it is selected from hydrogen or C1~C4 alkyl;C1~C4 alkyl includes Methyl, ethyl, propyl, isopropyl, butyl, isobutyl group, tertiary butyl and sec-butyl.
The method includes following step:
(1)
Formula (D) compound is obtained by raw material of formula (A) compound;Wherein, X represents Cl, Br or I;
(2)
In the presence of base, formula (E) compound is obtained by raw material of formula (D) compound;
(3)
Under acid condition, formula (E) compound and formula (F) compound are subjected to friedel-crafts acylation reaction, obtain formula (G) change Close object;
(4)
The carbonyl of reduction-type (G) compound obtains formula (H) compound;
(5)
The carboxyl that chloride formula (H) compound is obtains formula (J) compound;
(6)
Under acid condition, formula (J) compound is subjected to intramolecular friedel-crafts acylation reaction, obtains formula (I) compound.
Further, the R1、R2、R3、R4、R5And R6It is hydrogen, specifically, i.e. the following institute of structure of formula (I) compound Show,
Carry out as steps described below:
(1a)
Formula (Da) compound is obtained by raw material of formula (A) compound;Wherein, X represents Cl, Br or I;
(2a)
In the presence of base, formula (Ea) compound is obtained by raw material of formula (Da) compound;
(3a)
Under acid condition, formula (Ea) compound and formula (Fa) compound are subjected to friedel-crafts acylation reaction, obtain formula (Ga) Compound;
(4a)
The carbonyl of reduction-type (Ga) compound obtains formula (Ha) compound;
(5a)
The carboxyl of chloride formula (Ha) compound obtains formula (Ja) compound;
(6a)
Under acid condition, formula (Ja) compound is subjected to intramolecular friedel-crafts acylation reaction, obtains formula (I a) compound.
Further, the X is selected from Br.
Further, in step (2) or step (2a), the alkali is selected from potassium tert-butoxide or potassium carbonate, and the solvent of reaction selects From DMF, the tert-butyl alcohol or Isosorbide-5-Nitrae-dioxane.
Further, the alkali is selected from potassium tert-butoxide, and the solvent of reaction is selected from DMF.
Further, the temperature of reaction can be in 60 DEG C~90 DEG C, such as 60 DEG C.
Further, in step (3) or step (6), the friedel-crafts acylation reaction be in the presence of a lewis acid into Capable;Preferably, the lewis acid is selected from alchlor.
Further, in step (4), the method for the reducing carbonyl is Wolff-Kishner- huang-Minlon reductions.I.e. By carbonyls in high boiling solvent such as diglycol (such as diethylene glycol (DEG)), in the presence of sodium hydroxide or potassium hydroxide Under, with hydrazine reaction.
Further, in step (5), the chloride reagent of the chloride is thionyl chloride.
In the step of formula (D) compound is obtained using formula (A) compound as raw material (1), those skilled in the art can be used Known method can also be carried out by following routes:
(1-1)
Formula (B) compound is obtained by raw material of formula (A) compound;Wherein, Y represents hydroxyl, alkyl or alkoxy;
(1-2)
Suzuki cross-coupling reactions are carried out with formula (B) compound and formula (C) compound, obtain formula (D) compound.
Further, the Y represents hydroxyl.
Further, in step (1-1), when Y represents hydroxyl, formula (A) compound is reacted with organometallic reagent It is reacted with borate, formula (B) compound is obtained after acidification;
The organometallic reagent is Grignard Reagent, preferably isopropylmagnesium chloride or n-BuLi;The borate is preferred Trimethylborate or triisopropyl borate ester etc..
Further, in step (1-2), the catalyst of the Suzuki cross-coupling reactions is selected from four (triphenyl phosphorus) The bis- Diphenyl phosphino ferrocene palladium chlorides of palladium, 1,1'- or palladium, preferably four (triphenyl phosphorus) palladiums.
Further, in step (1-2), the catalyst alkali of the Suzuki cross-coupling reactions is selected from potassium carbonate or phosphoric acid Potassium is molten;Solvent is selected from THF, Isosorbide-5-Nitrae-dioxane or toluene;Reaction temperature is 60 DEG C~120 DEG C.
As it is a kind of more specifically, obtain the embodiment of Velpatasvir intermediates shown in formula (I a), it is specific Synthetic route is as follows:
(1) boration reacts
The synthesis of adjacent fluorobenzoic boric acid:O-fluorobenzyl bromide is dissolved in solvent, organometallic reagent is added dropwise under low temperature, then boron is added dropwise Acid esters is risen again overnight naturally.Reaction finishes, and pours into dilute hydrochloric acid, and extraction is concentrated to give adjacent fluorobenzoic boric acid.Solvent for use is THF, ether etc., temperature are 0 DEG C Dao -70 DEG C, and organometallic reagent is Grignard Reagent, such as isopropylmagnesium chloride or positive fourth Base lithium.Borate is trimethylborate, triisopropyl borate ester etc..
(2) Suzuki cross-coupling reactions
The synthesis of (the chloro- 2'- fluorine biphenyl -2- bases of 4-) methanol:By adjacent fluorobenzoic boric acid, (the bromo- 5- chlordiphenyls of 2-) methanol, alkali, Palladium catalyst, solvent add in reactor, heating stirring reaction certain time, and TLC tracking determines reaction end.Reaction finishes, Enter in ice water, extract, be concentrated to give (the chloro- 2'- fluorine biphenyl -2- bases of 4-) methanol.Alkali used is potassium carbonate, potassium phosphate etc., and solvent is THF, Isosorbide-5-Nitrae-dioxane, toluene etc., catalyst be four triphenyl phosphorus palladiums, 1,1'- bis- Diphenyl phosphino ferrocene palladium chlorides, vinegar Sour palladium etc., temperature is from 60 DEG C to 120 DEG C.
(3) intramolecular nucleophilic substitution reaction
The synthesis of chloro- 6 hydrogen of 8--benzo [c] chromene:By (the chloro- 2'- fluorine biphenyl -2- bases of 4-) methanol, alkali, the mixing of solvent Object heating stirring is reacted, TLC tracking reactions.Reaction finishes, and pours into ice water, and extraction is concentrated to give chloro- 6 hydrogen of 8--benzo [c] color Alkene.Alkali is potassium tert-butoxide, potassium carbonate etc., and solvent DMF, the tert-butyl alcohol, Isosorbide-5-Nitrae-dioxane, reaction temperature is 50 DEG C to 90 DEG C.
(4) intermolecular Friedel-Crafts acylation reactions
The synthesis of 4- (chloro- 6 hydrogen of 8--benzo [c] chromene -2- bases) -4- carbonyl butyric acid:By chloro- 6 hydrogen of 8--benzo [c] color Alkene, succinic anhydride are dissolved in dichloroethanes, and alchlor is then added portionwise, in 60 DEG C of reactions.Reaction finishes, and pours into ice water In, extraction, alkali cleaning, acidification, then extract, it is concentrated to give 4- (chloro- 6 hydrogen of 8--benzo [c] chromene -2- bases) -4- carbonyl butyric acid.
Huang Min-lon reduction
(5) Wolff-Kishner- Huang Min-lon reductions are reacted
The synthesis of 4- (chloro- 6 hydrogen of 8--benzo [c] chromene -2- bases) butyric acid:By 4- (chloro- 6 hydrogen of 8--benzo [c] chromene -2- Base) -4- carbonyl butyric acid, hydrazine hydrate, potassium hydroxide is dissolved in diethylene glycol (DEG), divides water between being warming up to 140 DEG C to 150 DEG C, divided water Afterwards, it is reacted between being warming up to 180 DEG C to 190 DEG C.Reaction finishes, and pours into ice water, adjusts acid, and extraction is concentrated to give 4- (8- chloro- 6 Hydrogen-benzo [c] chromene -2- bases) butyric acid.
(6) intramolecular Friedel-Crafts acylation reactions
The synthesis of compound I:By 4- (chloro- 6 hydrogen of 8--benzo [c] chromene -2- bases) butyric acid, DMF is dissolved in dichloromethane, Thionyl chloride is added dropwise, drips off temperature rising reflux reaction.Alchlor is added portionwise in cooling, and 10 DEG C or so reactions are to the reaction was complete. Enter in ice water, extract, be concentrated to give compound (Ia).
The present invention also provides the formula (D), formula (G) and formula (H) compounds;Further, R1、R2、R3、R4、R5With R6It is hydrogen namely formula (Da), formula (Ga) and formula (Ha) compound.These compounds can be as the system of Benzochromene derivatives Standby intermediate, especially formula (Da), formula (Ga) and formula (Ha) compound, can be as the Velpatasvir shown in formula (I a) Prepare intermediate, great market application value.
The method of the present invention provides one and completely new prepares benzo color using cheap and easily-available adjacent fluorine halogeno-benzene as initial feed The synthetic route of ene derivative, and the often step reaction of the synthetic route is screened and optimized.Entire reaction route is total High income is suitable for large-scale industrial production.
In the present invention, the corresponding Chinese full name of english abbreviation is as shown in the table:
Bu Tertiary butyl
DCM Dichloromethane
DMF N,N-dimethylformamide
DMSO Dimethyl sulfoxide (DMSO)
EA Ethyl acetate
MTBE Methyl tertiary butyl ether(MTBE)
Pd(dppf)Cl2 The bis- Diphenyl phosphino ferrocene palladium chlorides of 1,1'-
THF Tetrahydrofuran
Obviously, the above according to the present invention according to the ordinary technical knowledge and customary means of this field, is not departing from Under the premise of the above-mentioned basic fundamental thought of the present invention, the modification, replacement or change of other diversified forms can also be made.
The above of the specific embodiment present invention of form is described in further detail again by the following examples. But the range that this should not be interpreted as to the above-mentioned theme of the present invention is only limitted to following example.It is all real based on the above of the present invention institute Existing technology all belongs to the scope of the present invention.
Specific embodiment
The preparation of 1 compound 2 of embodiment
1 4kg of compound (22.9mol) is sequentially added in 50L reaction kettles under nitrogen protection, THF20L is cooled to -70 ℃.N-BuLi 6.8kg are added dropwise below -70 DEG C of temperature control, drip off 0.5 hour stirred below after -70 DEG C.It is dripped below -70 DEG C of temperature control Add triisopropyl borate ester 4.75kg, rise again naturally after dripping off overnight.It pours into 20L (1N) dilute hydrochloric acid, liquid separation, water phase is used again EA10L extractions are primary.Merge organic phase, washed once with saturated salt solution 10L, anhydrous sodium sulfate drying is filtered, and concentration must be changed Close 2 2.4kg of object, yield 85%.
The preparation of 2 compound 4 of embodiment
Method 1:
Compound 3 500g, THF3L, 2 382g of compound, potassium carbonate are added in 10L four-hole bottles successively under nitrogen protection 626g, deionized water 3L, four (triphenyl phosphorus palladium) 6g are warming up to back flow reaction and stay overnight.The reaction was complete (about 16 hours) for TLC monitoring After pour into 3L ice water, liquid separation, water phase EA1L extracts primary.Merge organic phase, washed once with saturated salt solution 2L, anhydrous sulphur Sour sodium drying, filtering are concentrated to give 4 482g of compound, yield 96%.
HNMR(CDCl3,400MHz):δ7.62(s,1H),7.49-7.11(m,6H),4.69(1H,s),4.50(2H,s).
Method 2:
Compound 3 50g, THF 300mL, 2 38.2g of compound, carbon are added in 10L four-hole bottles successively under nitrogen protection Sour potassium 62.6g, deionized water 300mL, Pd (dppf) Cl20.6g is warming up to back flow reaction 20h.TLC monitoring is after the reaction was complete It pours into 500mL ice water, liquid separation, water phase EA 300mL extract primary.Merge organic phase, one is washed with saturated salt solution 200mL Secondary, anhydrous sodium sulfate drying, filtering is concentrated to give 4 42.8g of compound, yield 80%, HPLC=88%.
As can be seen that when catalyst is four (triphenyl phosphorus palladium), the yield of target product is higher.
The preparation of 3 compound 5 of embodiment
Method 1:
Under nitrogen protection, compound 4 50g, DMSO 500mL, potassium tert-butoxide 35.6g are sequentially added in 1L four-hole bottles, 60 DEG C are warming up to react 1 hour.TLC monitoring raw materials disappear, and pour into 1L ice water, are extracted with MTBE 1L x 3.Merge organic Phase is washed once with water 1L, and saturated salt solution 1L is washed once, and anhydrous sodium sulfate drying, filtering is concentrated to give compound 37.5g, receives Rate 82%, HPLC=90%.
Method 2:
Under nitrogen protection, compound 4 50g, DMF 500mL, K are sequentially added in 1L four-hole bottles2CO343.7g heating It is reacted 1 hour to 60 DEG C.TLC monitoring raw materials disappear, and pour into 1L ice water, are extracted with MTBE 1L x 3.Merge organic phase, use Water 1L is washed once, and saturated salt solution 1L is washed once, and anhydrous sodium sulfate drying, filtering is concentrated to give 5 29.8g of compound, yield 65%, HPLC=85%.
Method 3:
Under nitrogen protection, compound 4 482g, DMF5L, potassium tert-butoxide 347g are sequentially added in 10L four-hole bottles, is heated up It is reacted 0.5 hour to 60 DEG C.TLC monitoring raw materials disappear, and pour into 10L ice water, are extracted with MTBE10L x 3.Merge organic phase, It is washed once with water 10L, saturated salt solution 10L is washed once, and anhydrous sodium sulfate drying, filtering is concentrated to give 5 419g of compound, receives Rate 95%.
HNMR(CDCl3,400MHz):δ 7.67 (d, 1H, J=8.0Hz), 7.60 (d, 1H, J=8.4Hz), 7.33 (d, 1H, J=8.0Hz), 7.22 (m, 1H), 7.13 (s, 1H), 7.04 (m, 1H), 6.97 (d, 1H, J=8.0Hz), 5.06 (s, 2H)
As can be seen that when using potassium tert-butoxide, and solvent is DMF, the yield of target product is higher.
The preparation of 4 compound 6 of embodiment
Under nitrogen protection, compound 5 419g, dichloroethanes 3L, succinic anhydride 194g are sequentially added in 10L four-hole bottles. Less than 40 DEG C are added portionwise alchlor 388g, after adding, are warming up to 60 DEG C and react 1 hour.TLC monitoring raw materials disappear, and pour into In 6L ice water, liquid separation, water phase is extracted with DCM3L x 2.Merge organic phase, wash organic phase with 1N sodium hydrate aqueous solutions, give up Organic phase.Water phase 6N hydrochloric acid tune pH=1, are extracted with EA/THF (1/3) 2L x 3.Merge organic phase, with saturated salt solution 2L It washes once, anhydrous sodium sulfate drying, filtering is concentrated to give 6 313g of compound, yield 86%.
HNMR(CDCl3,400MHz):δ 8.36 (s, 1H), 7.87 (d, 1H, d=8.0Hz), 7.71 (d, 1H, J= 8.0Hz), 7.39 (d, 1H, J=8.4Hz), 7.16 (s, 1H), 7.02 (d, 1H, J=8.4Hz), 5.15 (s, 2H), 3.32 (t, 2H, J=6.4Hz), 2.83 (t, 2H, J=6.4Hz)
The preparation of 5 compound 7 of embodiment
Wolff-Kishner- huang-Minlon reductions:
Under nitrogen protection, compound 6 313g, diethylene glycol (DEG) 2.5L, hydrazine hydrate 187g, hydrogen are sequentially added in 10L four-hole bottles Potassium oxide 224g.Finish, water divided between being warming up to 140 DEG C to 150 DEG C 3 hours, after having divided water, be warming up to 180 DEG C to 190 DEG C it Between react 2 hours.The reaction was complete for TLC monitoring.Cooling, pours into ice water 10L, with 6N hydrochloric acid tune pH=1, is extracted with EA 3L x 3 It takes.Merge organic phase, washed once with saturated salt solution 3L, anhydrous sodium sulfate drying, filtering is dense, dense to obtain 7 240g of compound, receives Rate 91%.
Control methods:
Under nitrogen protection, compound 6 10g, THF 200mL, trifluoroacetic acid 6g are sequentially added in 10L four-hole bottles, is added dropwise After 20 DEG C of temperature control is hereinafter, drip off, 8h is stirred at room temperature in triethylsilane 8g.The reaction was complete for TLC monitoring.It pours into ice water 200mL, It is extracted with EA 200mL x 3.Merge organic phase, washed once with saturated salt solution 200mL, anhydrous sodium sulfate drying is filtered, dense Contract to obtain 7 2g of compound, yield 20%, HPLC=88%.
As can be seen that during the carbonyl of this step selection Wolff-Kishner- huang-Minlon reductions reducing compound 6, yield is bright It is aobvious more excellent.
The preparation of embodiment 6Velpatasvir intermediates (Ia)
Under nitrogen protection, 7 185g of compound, dichloromethane 4L, DMF1mL are sequentially added in 10L four-hole bottles.Temperature control 20 DEG C hereinafter, be added dropwise thionyl chloride 109g, back flow reaction is warming up to after dripping off 1 hour.Cool down, three are added portionwise below 10 DEG C of temperature control Aluminium chloride 122g adds recession except ice bath, and 10 DEG C or so are reacted 0.5 hour.TLC monitoring raw materials disappear.It pours into ice water 3L, point Liquid, water phase are extracted with DCM 1.5L x 2.Merge organic phase, washed once with 1N sodium hydrate aqueous solutions 2L, saturated salt solution 2L It washes once, anhydrous sodium sulfate drying, filtering is concentrated to give Velpatasvir intermediates (Ia) 155g, yield 95%, purity 94% (HPLC)。
HNMR(CDCl3,400MHz):δ 7.60 (d, 1H, J=8.0Hz), 7.58 (s, 1H), 7.50 (s, 1H), 7.30 (d, 1H, J=8.0Hz), 7.13 (d, 1H), 5.02 (s, 2H), 2.92 (t, 2H, J=6.0Hz), 2.61 (t, 2H, J=6.8Hz), 2.12(m,2H).
In conclusion the method for the present invention using cheap and easily-available adjacent fluorine halogeno-benzene as initial feed, provide one it is completely new The synthetic route of Benzochromene derivatives is prepared, entire reaction route total recovery is high, is suitable for large-scale industrial production.

Claims (17)

1. a kind of method of formula (I) compound, including its racemic mixture or chipal compounds:
Wherein, R1、R2、R3、R4、R5And R6Separately it is selected from hydrogen or C1~C4 alkyl;
The method includes following step:
(1)
Formula (D) compound is obtained by raw material of formula (A) compound;Wherein, X represents Cl, Br or I;
(2)
In the presence of base, formula (E) compound is obtained by raw material of formula (D) compound;
(3)
Under acid condition, formula (E) compound and formula (F) compound are subjected to friedel-crafts acylation reaction, obtain formula (G) compound;
(4)
The carbonyl of reduction-type (G) compound obtains formula (H) compound;
(5)
The carboxyl of chloride formula (H) compound obtains formula (J) compound;
(6)
Under acid condition, formula (J) compound is subjected to intramolecular friedel-crafts acylation reaction, obtains formula (I) compound.
2. according to the method described in claim 1, it is characterized in that:The R1、R2、R3、R4、R5And R6It is hydrogen.
3. method according to claim 1 or 2, it is characterised in that:The X is selected from Br.
4. according to the method described in claim 3, it is characterized in that:In step (2), the alkali is selected from potassium tert-butoxide or carbonic acid Potassium, the solvent of reaction are selected from DMF, the tert-butyl alcohol or Isosorbide-5-Nitrae-dioxane.
5. according to the method described in claim 4, it is characterized in that:The alkali is selected from potassium tert-butoxide, and the solvent of reaction is selected from DMF。
6. according to the method described in claim 3, it is characterized in that:In step (3) or step (6), the friedel-craft is acylated anti- It should carry out in the presence of a lewis acid.
7. according to the method described in claim 6, it is characterized in that:The lewis acid is selected from alchlor.
8. according to the method described in claim 3, it is characterized in that:In step (4), the method for the reducing carbonyl is Wolff- Kishner- huang-Minlon reductions.
9. according to the method described in claim 3, it is characterized in that:In step (5), the chloride reagent of the chloride is chlorine Change sulfoxide.
10. according to claim 1-2,4-7 any one of them method, it is characterised in that:The step (1) includes following steps Suddenly:
(1-1)
Formula (B) compound is obtained by raw material of formula (A) compound;Wherein, Y represents hydroxyl, alkyl or alkoxy;
(1-2)
Suzuki cross-coupling reactions are carried out with formula (B) compound and formula (C) compound, obtain formula (D) compound.
11. according to the method described in claim 10, it is characterized in that:The Y represents hydroxyl.
12. according to the method for claim 11, it is characterised in that:In step (1-1), by formula (A) compound and organic gold Belong to reagent reaction and borate reaction, formula (B) compound is obtained after acidification;
The organometallic reagent is Grignard Reagent.
13. according to the method for claim 12, it is characterised in that:The organometallic reagent be selected from isopropylmagnesium chloride or N-BuLi;The borate is selected from trimethylborate or triisopropyl borate ester.
14. according to the method for claim 11, it is characterised in that:In step (1-2), the Suzuki cross-coupling reactions Catalyst be selected from four (triphenyl phosphorus) palladiums, the bis- Diphenyl phosphino ferrocene palladium chlorides of 1,1'- or palladium.
15. according to the method for claim 14, it is characterised in that:The catalyst is selected from four (triphenyl phosphorus) palladiums.
16. according to 11,14,15 any one of them method of claim, it is characterised in that:In step (1-2), the Suzuki The catalyst alkali of cross-coupling reaction is selected from potassium carbonate or potassium phosphate;Solvent is selected from THF, Isosorbide-5-Nitrae-dioxane or toluene;Reaction Temperature is 60 DEG C~120 DEG C.
17. formula (G) described in claim 1 and formula (H) compound, it is characterised in that:The R1、R2、R3、R4、R5And R6It is Hydrogen.
CN201610225503.8A 2016-04-12 2016-04-12 A kind of preparation method of Benzochromene derivatives Active CN105801553B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610225503.8A CN105801553B (en) 2016-04-12 2016-04-12 A kind of preparation method of Benzochromene derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610225503.8A CN105801553B (en) 2016-04-12 2016-04-12 A kind of preparation method of Benzochromene derivatives

Publications (2)

Publication Number Publication Date
CN105801553A CN105801553A (en) 2016-07-27
CN105801553B true CN105801553B (en) 2018-06-19

Family

ID=56459993

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610225503.8A Active CN105801553B (en) 2016-04-12 2016-04-12 A kind of preparation method of Benzochromene derivatives

Country Status (1)

Country Link
CN (1) CN105801553B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107311852A (en) * 2017-06-27 2017-11-03 上海同昌生物医药科技有限公司 A kind of synthetic method of Wei Patawei intermediate As

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101932325A (en) * 2007-11-30 2010-12-29 新联基因公司 Ido inhibitors
EP2907816A1 (en) * 2011-11-16 2015-08-19 Gilead Pharmasset LLC Condensed imidazolylimidazoles as antiviral compounds
CN105294713A (en) * 2015-10-09 2016-02-03 重庆康施恩化工有限公司 Velpatasvir intermediate and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101932325A (en) * 2007-11-30 2010-12-29 新联基因公司 Ido inhibitors
EP2907816A1 (en) * 2011-11-16 2015-08-19 Gilead Pharmasset LLC Condensed imidazolylimidazoles as antiviral compounds
CN105294713A (en) * 2015-10-09 2016-02-03 重庆康施恩化工有限公司 Velpatasvir intermediate and preparation method thereof

Also Published As

Publication number Publication date
CN105801553A (en) 2016-07-27

Similar Documents

Publication Publication Date Title
CN106478504B (en) Method for preparing Roxadustat intermediate
CN107963958A (en) The synthetic method of trans- 4- (trans- 4 '-alkyl-cyclohexyl) cyclohexyl. vinyl liquid crystal monomer
CN104876956B (en) The technique of one pot process boron aminated compounds
JP2022508494A (en) Method for Producing Morpholine Quinazoline Compound and its Intermediate
CN106674264A (en) Synthetic method for (2,2,2-trifluoroethoxyl) phenylboronic acid compounds
CN108774129A (en) The method that visible light catalytic organic boronic prepares esters of alpha, beta, unsaturated carboxylic acids derivative
CN105801553B (en) A kind of preparation method of Benzochromene derivatives
CN108558916B (en) Synthesis process of p-phenylbutoxy benzoic acid
CN106518822B (en) The synthetic method of witchweed lactone (±)-GR24 and (±)-GR24 of 4 substitutions
CN113248432A (en) Novel method for preparing intermediate of roxasistat in high yield
CN115466206B (en) Preparation method of 2-acetyl-1-pyrroline
CN106905227A (en) The preparation method of aryl-linking compound
CN109970773A (en) A kind of new synthetic method of N-Boc-1,2,5,6- tetrahydropyridine -4- pinacol borate
CN109867659A (en) The preparation method of benzo piperidine derivatives
CN104447262B (en) Method for synthesizing 1-chloro-1-chloroacetyl-cyclopropane by one-pot method
CN109651241B (en) Synthesis method of 4-bromo-6-chloronicotinaldehyde
CN106866608B (en) A kind of preparation method of fluoro -3,4- dihydrocoumarin derivative
CN106187969B (en) A kind of preparation method of 4- aryl-coumarin class compound
CN106431824A (en) Industrial production method of 3,3'-difluorobiphenyl
CN114181112B (en) Preparation method of 2, 6-diethyl-4-methylphenyl malononitrile
CN112159347B (en) Preparation method of picolitamide
CN108299169B (en) Synthesis method of 6-chloro-3, 4-dihydro-2H-1-naphthalenone
CN111302930B (en) Preparation method of p-phenylbutoxy benzoic acid
CN117143108B (en) 8-bromo-2-methylbenzofuran [2,3-b ] pyridine and synthetic method
CN107602339A (en) A kind of method for synthesizing 4 hydroxymethyl biphenyls

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A Preparation Method of Benzo Chromene Derivatives

Effective date of registration: 20230914

Granted publication date: 20180619

Pledgee: Shanghai Pudong Development Bank Co.,Ltd. Chengdu Branch

Pledgor: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp.

Registration number: Y2023510000215

PE01 Entry into force of the registration of the contract for pledge of patent right